Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel R Beisner

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2009
Inositol 1,4,5-trisphosphate 3-kinase B is a negative regulator of BCR signaling that controls B cell selection and tolerance inductionAndrew T Miller, Daniel R Beisner, Daorong Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 9, 2005
Cutting edge: innate immunity conferred by B cells is regulated by caspase-8Daniel R Beisner, Irene L Ch'en, Ravi V Kolla, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2003
The requirements for Fas-associated death domain signaling in mature T cell activation and survivalDaniel R Beisner, Isaac H Chu, Adrian F Arechiga, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 5, 2008
Antigen-mediated T cell expansion regulated by parallel pathways of deathIrene L Ch'en, Daniel R Beisner, Alexei Degterev, et al.
Nature Immunology|January 13, 2009
Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptorYann M Kerdiles, Daniel R Beisner, Roberto Tinoco, et al.
Nature Immunology|April 14, 2009
Transcription factor Foxo3 controls the magnitude of T cell immune responses by modulating the function of dendritic cellsAnne S Dejean, Daniel R Beisner, Irene L Ch'en, et al.
Immunity|December 21, 2010
Foxo transcription factors control regulatory T cell development and functionYann M Kerdiles, Erica L Stone, Daniel R Beisner, et al.
Journal of Medicinal Chemistry|January 24, 2018
Discovery of the First Potent, Selective, and Orally Bioavailable Signal Peptide Peptidase-Like 2a (SPPL2a) Inhibitor Displaying Pronounced Immunomodulatory Effects In VivoJuraj Velcicky, Ursula Bodendorf, Pascal Rigollier, et al.
ACS Medicinal Chemistry Letters|June 22, 2019
Discovery of Orally Active Hydroxyethylamine Based SPPL2a InhibitorsJuraj Velcicky, Casey J N Mathison, Victor Nikulin, et al.
The Journal of Experimental Medicine|December 26, 2012
The intramembrane protease Sppl2a is required for B cell and DC development and survival via cleavage of the invariant chainDaniel R Beisner, Petra Langerak, Albert E Parker, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2009
Inositol 1,4,5-trisphosphate 3-kinase B is a negative regulator of BCR signaling that controls B cell selection and tolerance inductionAndrew T Miller, Daniel R Beisner, Daorong Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 9, 2005
Cutting edge: innate immunity conferred by B cells is regulated by caspase-8Daniel R Beisner, Irene L Ch'en, Ravi V Kolla, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2003
The requirements for Fas-associated death domain signaling in mature T cell activation and survivalDaniel R Beisner, Isaac H Chu, Adrian F Arechiga, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 5, 2008
Antigen-mediated T cell expansion regulated by parallel pathways of deathIrene L Ch'en, Daniel R Beisner, Alexei Degterev, et al.
Nature Immunology|January 13, 2009
Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptorYann M Kerdiles, Daniel R Beisner, Roberto Tinoco, et al.
Nature Immunology|April 14, 2009
Transcription factor Foxo3 controls the magnitude of T cell immune responses by modulating the function of dendritic cellsAnne S Dejean, Daniel R Beisner, Irene L Ch'en, et al.
Immunity|December 21, 2010
Foxo transcription factors control regulatory T cell development and functionYann M Kerdiles, Erica L Stone, Daniel R Beisner, et al.
Journal of Medicinal Chemistry|January 24, 2018
Discovery of the First Potent, Selective, and Orally Bioavailable Signal Peptide Peptidase-Like 2a (SPPL2a) Inhibitor Displaying Pronounced Immunomodulatory Effects In VivoJuraj Velcicky, Ursula Bodendorf, Pascal Rigollier, et al.
ACS Medicinal Chemistry Letters|June 22, 2019
Discovery of Orally Active Hydroxyethylamine Based SPPL2a InhibitorsJuraj Velcicky, Casey J N Mathison, Victor Nikulin, et al.
The Journal of Experimental Medicine|December 26, 2012
The intramembrane protease Sppl2a is required for B cell and DC development and survival via cleavage of the invariant chainDaniel R Beisner, Petra Langerak, Albert E Parker, et al.
Pageof 2